104 related articles for article (PubMed ID: 8260246)
1. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro.
Angus R; Collins CM; Symes MO
Eur J Cancer; 1993; 29A(13):1879-85. PubMed ID: 8260246
[TBL] [Abstract][Full Text] [Related]
2. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
3. [Expression on major histocompatibility complex antigen and effect of IFN-alpha on renal cell carcinoma].
Nagata M
Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):814-21. PubMed ID: 8320886
[TBL] [Abstract][Full Text] [Related]
4. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
5. [Expression of major histocompatibility complex antigens and adhesion molecules on renal cell carcinoma cells, and effect of interferon-alpha and/or cimetidine on the expression].
Wu XX; Mizutani Y; Kakehi Y; Nakamura E; Mitsumori K; Takahashi T; Terachi T; Okada Y; Yoshida O
Hinyokika Kiyo; 1998 Sep; 44(9):621-6. PubMed ID: 9805665
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
Hoon DS; Okun E; Banez M; Irie RF; Morton DL
Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro.
Yanai Y; Horie S; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M; Kitamura T
J Interferon Cytokine Res; 2001 Dec; 21(12):1129-36. PubMed ID: 11798471
[TBL] [Abstract][Full Text] [Related]
8. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes.
Satoh J; Paty DW; Kim SU
Neurology; 1995 Feb; 45(2):367-73. PubMed ID: 7854540
[TBL] [Abstract][Full Text] [Related]
10. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
12. Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma.
Martin M; Schwinzer R; Schellekens H; Resch K
J Immunol; 1989 Mar; 142(6):1887-94. PubMed ID: 2493501
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells.
Semino C; Ferlazzo G; Pietra G; Pasquetti W; Repetto L; Rosso R; Mariani M; Melioli G
J Biol Regul Homeost Agents; 1993; 7(3):99-105. PubMed ID: 8135147
[TBL] [Abstract][Full Text] [Related]
15. [Interferon-induced protection of renal cell cancer cell lines to lymphokine-activated killer (LAK) cells and effect of acid treatment on their susceptibility. Its relevance to expression of major histocompatibility complex class I antigens on tumor cells].
Tomita Y; Kimura M; Nishiyama T; Sato S
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):762-8. PubMed ID: 1908533
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
[TBL] [Abstract][Full Text] [Related]
17. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
18. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells.
Ponzoni M; Guarnaccia F; Corrias MV; Cornaglia-Ferraris P
Int J Cancer; 1993 Nov; 55(5):817-23. PubMed ID: 8244579
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
[TBL] [Abstract][Full Text] [Related]
20. [Study on the combined therapy of DNA-methyltransferase inhibitor and interferon-alpha/beta for mouse spontaneously arose renal cell carcinoma, and immunological mechanism induced by the therapy].
Onishi T; Ohishi Y; Goto H; Suzuki H; Asano K; Hatano T; Abe K; Tomita M; Imagawa K
Nihon Hinyokika Gakkai Zasshi; 1998 Oct; 89(10):828-35. PubMed ID: 9844399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
